Editorial Policy

This page documents the editorial standards that govern all content published on Medica Intelligence. These standards apply to every content type and every contributor.

Source Standards by Content Type

Research Digests

Research Digests are sourced exclusively from peer-reviewed journals, including but not limited to NEJM AI, JAMA Network, JAMA Network Open, npj Digital Medicine, and PubMed Central. Vendor white papers, press releases, and non-peer-reviewed preprints are excluded from Research Digests unless explicitly labeled as pre-prints with that label visible in the digest header. Industry-funded studies are flagged with a funding disclosure indicator in the structured evidence panel.

Policy & Regulation

Every Policy & Regulation item cites the primary source document — Federal Register notices, FDA guidance PDFs, WHO publications, ONC rulemakings, or CMS decisions — with a direct external link. Items carry a last-reviewed date indicating when the editorial team last verified the item against the primary source. Status badges (proposed, final, under revision, withdrawn, superseded) reflect the document's current binding status at the time of last review.

Technology Profiles

Technology Profiles are factual and source-cited. They do not contain editorial opinion about vendor merit. Profiles carry a last-updated date. Evidence quality assessments reference specific published studies; manufacturer-sponsored studies without independent validation are disclosed as such. FDA clearance status is drawn from the FDA's official AI-enabled medical devices database or from the FDA 510(k), De Novo, or PMA databases.

Clinical Applications

Clinical Applications explainers are grounded in published implementation literature and institutional reports. The evidence basis field on each explainer discloses whether the workflow description is based on peer-reviewed implementation studies, institutional reports, or FDA-cleared device labeling.

Health Equity & Algorithmic Bias

All bias claims and equity analyses cite primary research and policy sources, including peer-reviewed studies, KFF reports, WHO equity guidance, and FDA equity frameworks. Editorial claims about disparate AI performance are not made without a primary evidence source.

Glossary

Glossary entries carry a last-reviewed date. Entries for regulatory terminology (SaMD, PCCP, De Novo, etc.) are reviewed when FDA or WHO guidance documents are updated. Entries for AI/ML methodology terms are reviewed as technical usage evolves in peer-reviewed literature.

Data & Statistics

All data pages cite primary sources and disclose methodology. Market size figures are presented as ranges with source attribution rather than single authoritative numbers, given wide variance across research firms. Data pages carry a data-as-of date indicating the time period reflected by the data, distinct from the page publication date.

Review and Update Process

Policy & Regulation items and Glossary entries carry last-reviewed dates. Technology Profiles carry last-updated dates. These dates indicate when the editorial team last verified the content against primary sources.

Corrections are accepted via the contact page. Corrections to structured fields (regulatory status, evidence quality assessments, funding disclosures) are given priority review. Accepted corrections are applied to the content and reflected in the updated or last-reviewed date.

Conflict-of-Interest Policy

Contributors to Technology Profiles, Research Digests, and Policy & Regulation items are required to disclose any financial relationships with companies or organizations whose products or guidance are covered in their contributions. Contributions with undisclosed conflicts of interest are not published.

Research Digests carry the funding disclosure from the original study as a structured field. Studies with industry funding and no independent validation are noted as such in the evidence quality assessment.